Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq.

Madigan Army Medical Center and VA Northwest Network Mental Illness, VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USA.
Journal of Traumatic Stress (Impact Factor: 2.72). 10/2010; 23(5):645-8. DOI: 10.1002/jts.20570
Source: PubMed

ABSTRACT Trauma nightmares and sleep disturbance impair combat soldiers' functioning. The alpha-1 adrenoreceptor antagonist prazosin has been demonstrated effective for these symptoms in Vietnam veterans. Thirteen soldiers seeking relief from distressing trauma nightmares impairing military function in northern Iraq in 2006 received prazosin alone or in combination with other psychotropics. Mean prazosin dose was 4.1 (SD = 2.2) mg before bed. Six soldiers improved markedly and 3 moderately on the Clinical Global Impression of Change Ratings of distressing dreams decreased from an average of 7.0 (SD = 0.7) to 2.9 (SD = 3.0, p < .001) and those of disturbed sleep from 6.7 (SD = 0.9) to 3.7 (SD = 2.4, p < .001). Prazosin appears effective and well tolerated in the desert warfare environment.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Initial posttraumatic stress disorder (PTSD) care is often delayed and many with PTSD go untreated. Acupuncture appears to be a safe, potentially nonstigmatizing treatment that reduces symptoms of anxiety, depression, and chronic pain, but little is known about its effect on PTSD. Methods: Fifty-five service members meeting research diagnostic criteria for PTSD were randomized to usual PTSD care (UPC) plus eight 60-minute sessions of acupuncture conducted twice weekly or to UPC alone. Outcomes were assessed at baseline and 4, 8, and 12 weeks postrandomization. The primary study outcomes were difference in PTSD symptom improvement on the PTSD Checklist (PCL) and the Clinician administered PTSD Scale (CAPS) from baseline to 12-week follow-up between the 2 treatment groups. Secondary outcomes were depression, pain severity, and mental and physical health functioning. Mixed model regression and t test analyses were applied to the data. Results: Mean improvement in PTSD severity was significantly greater among those receiving acupuncture than in those receiving UPC (PCLD = 19.8 ± 13.3 vs. 9.7 ± 12.9, P < 0.001; CAPSD = 35.0± 20.26 vs. 10.9 ± 20.8, P < 0.0001). Acupuncture was also associated with significantly greater improvements in depression, pain, and physical and mental health functioning. Pre-post effect-sizes for these outcomes were large and robust. Conclusions: Acupuncture was effective for reducing PTSD symptoms. Limitations included small sample size and inability to parse specific treatment mechanisms. Larger multisite trials with longer follow-up, comparisons to standard PTSD treatments, and assessments of treatment acceptability are needed. Acupuncture is a novel therapeutic option that may help to improve population reach of PTSD treatment.
    Medical Care 12/2014; 52(12 (Supplement 5)):S57. · 2.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Post-traumatic stress disorder (PTSD) is one of the few mental disorders in which the cause is readily identifiable. In this article, we review the new Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria, prevalence, and presentation of patients with PTSD in primary care. The purpose of this article is to review current literature regarding theory, etiology, and treatment effectiveness. Key findings in terms of neurobiological underpinnings with implications for future treatment are discussed. Recommendations regarding effective psychotherapy and pharmacotherapy, emerging treatment, and management issues in primary care settings are offered.
    The International Journal of Psychiatry in Medicine 01/2014; 47(4):337-346. · 0.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Improved access to effective primary care-based treatments for PTSD may permit early intervention among previously underserved service members, thereby improving long-term outcomes. This randomized controlled trial examined the efficacy of DESTRESS-PC, a brief, self-directed, cognitive-behavioral, web-based intervention specifically tailored to the treatment of war-related Posttraumatic Stress Disorder (PTSD), compared to Optimized Usual Primary Care PTSD Treatment (OUC). Participants were 80 veterans of recent military conflicts with PTSD seeking primary care treatment at one of three Veterans Affairs (VA) and four Army clinics. DESTRESS-PC consisted of logins to a secure website three times per week for six weeks and monitoring by a study nurse. All participants received nurse care management in the form of phone check-ins every two weeks and feedback to their primary care providers. Blinded raters assessed outcomes 6, 12, and 18 weeks post-randomization. Study hypotheses were partially supported. DESTRESS-PC was associated with a significantly greater decrease in PTSD (PCLprimary outcome) and depression (PHQ-8) symptoms compared to OUC at the 12-week assessment (PCL = 12.616.6 versus 5.712.5, p<0.05; PHQ-8 = 3.6 4.9 versus 1.54.4, p<.05). VA participants (but not DoD participants) evidenced a similar pattern of results; yet, between-group effect sizes were larger, ranging from .30 to .59. Notably, there was a dose effect: the number of logins correlated significantly with PTSD outcomes. None of the other secondary outcomes (anxiety, somatic symptoms, and functional status) were significant. DESTRESS-PC offers promise as a means of delivering effective, early PTSD treatment in primary care to reduce chronicity, particularly for Veterans.
    141st APHA Annual Meeting and Exposition 2013; 11/2013


Available from